Literature DB >> 22694900

Genotyping hepatitis B virus dual infections using population-based sequence data.

Bastian Beggel1, Maria Neumann-Fraune2, Matthias Döring1, Glenn Lawyer1, Rolf Kaiser2, Jens Verheyen2, Thomas Lengauer1.   

Abstract

The hepatitis B virus (HBV) is classified into distinct genotypes A-H that are characterized by different progression of hepatitis B and sensitivity to interferon treatment. Previous computational genotyping methods are not robust enough regarding HBV dual infections with different genotypes. The correct classification of HBV sequences into the present genotypes is impaired due to multiple ambiguous sequence positions. We present a computational model that is able to identify and genotype inter- and intragenotype dual infections using population-based sequencing data. Model verification on synthetic data showed 100 % accuracy for intergenotype dual infections and 36.4 % sensitivity in intragenotype dual infections. Screening patient sera (n = 241) revealed eight putative cases of intergenotype dual infection (one A-D, six A-G and one D-G) and four putative cases of intragenotype dual infection (one A-A, two D-D and one E-E). Clonal experiments from the original patient material confirmed three out of three of our predictions. The method has been integrated into geno2pheno([hbv]), an established web-service in clinical use for analysing HBV sequence data. It offers exact and detailed identification of HBV genotypes in patients with dual infections that helps to optimize antiviral therapy regimens. geno2pheno([hbv]) is available under http://www.genafor.org/g2p_hbv/index.php.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22694900     DOI: 10.1099/vir.0.043042-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

Review 1.  Overview of hepatitis B viral replication and genetic variability.

Authors:  Shuping Tong; Peter Revill
Journal:  J Hepatol       Date:  2016-04       Impact factor: 25.083

2.  geno2pheno[ngs-freq]: a genotypic interpretation system for identifying viral drug resistance using next-generation sequencing data.

Authors:  Matthias Döring; Joachim Büch; Georg Friedrich; Alejandro Pironti; Prabhav Kalaghatgi; Elena Knops; Eva Heger; Martin Obermeier; Martin Däumer; Alexander Thielen; Rolf Kaiser; Thomas Lengauer; Nico Pfeifer
Journal:  Nucleic Acids Res       Date:  2018-07-02       Impact factor: 16.971

3.  HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons.

Authors:  Florian Bihl; Gladys Martinetti; Gilles Wandeler; Rainer Weber; Bruno Ledergeber; Alexandra Calmy; Manuel Battegay; Matthias Cavassini; Pietro Vernazza; Anna-Paola Caminada; Martin Rickenbach; Enos Bernasconi
Journal:  BMC Gastroenterol       Date:  2015-07-08       Impact factor: 3.067

4.  Molecular epidemiology of hepatitis B virus infection in Switzerland: a retrospective cohort study.

Authors:  Cédric Hirzel; Gilles Wandeler; Marta Owczarek; Meri Gorgievski-Hrisoho; Jean-Francois Dufour; Nasser Semmo; Samuel Zürcher
Journal:  BMC Infect Dis       Date:  2015-10-30       Impact factor: 3.090

5.  Widespread hepatitis B virus genotype G (HBV-G) infection during the early years of the HIV epidemic in the Netherlands among men who have sex with men.

Authors:  Marion Cornelissen; Fokla Zorgdrager; Sylvia M Bruisten; Margreet Bakker; Ben Berkhout; Antoinette C van der Kuyl
Journal:  BMC Infect Dis       Date:  2016-06-10       Impact factor: 3.090

6.  BATVI: Fast, sensitive and accurate detection of virus integrations.

Authors:  Chandana Tennakoon; Wing Kin Sung
Journal:  BMC Bioinformatics       Date:  2017-03-14       Impact factor: 3.169

Review 7.  A meta-analysis on genetic variability of RT/HBsAg overlapping region of hepatitis B virus (HBV) isolates of Bangladesh.

Authors:  Md Golzar Hossain; Keiji Ueda
Journal:  Infect Agent Cancer       Date:  2019-11-07       Impact factor: 2.965

8.  High prevalence of hepatitis B virus dual infection with genotypes A and G in HIV-1 infected men in Amsterdam, the Netherlands, during 2000-2011.

Authors:  Antoinette C van der Kuyl; Fokla Zorgdrager; Boris Hogema; Margreet Bakker; Suzanne Jurriaans; Nicole K T Back; Ben Berkhout; Hans L Zaaijer; Marion Cornelissen
Journal:  BMC Infect Dis       Date:  2013-11-14       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.